Lipids Health Prime Time™: Episode 2 Expert Opinions on the Role of Nonstatin Therapies: Exploring the Evidence for New and Emerging Nonstatin Options

Access Activity

Overview / Abstract:

This activity has been designed to address the educational needs of cardiologists and primary care physicians, including lipid specialists, internists, family physicians, pharmacists, nurses, nurse practitioners, and PAs.
This fast-paced news broadcast features expert discussions about incorporating new and emerging nonstatin therapies for the lowering of low-density lipoprotein cholesterol (LDL-C) into clinical practice.
At the conclusion of this activity, all participants should be able to:
• Distinguish among current and emerging nonstatin LDL-C therapies based on unique characteristics and clinical profiles
• Develop evidence-based treatment plans for at-risk patients who require additional lowering of LDL-C levels beyond statin therapy, considering patient preferences and accessibility/coverage
• Discuss strategies to improve the knowledge, skills, or performance of the healthcare team


Nov 30, 2022


Nursing CNE, Pharmacy CPE, Physician CME



Credits / Hours




Presenters / Authors / Faculty

Michelle L. O’Donoghue, MD, MPH
Joseph J. Saseen, PharmD, CLS, FNLA
Daniel E. Soffer, MD, FNLA, FACP

Sponsors / Supporters / Grant Providers

Novartis Pharmaceuticals Corporation

Keywords / Search Terms

Relias LLC Relias LLC Relias, Free CME, Nonstatin Therapies Free CE CME Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map